395
Views
0
CrossRef citations to date
0
Altmetric
Article Commentary

Adding to the CASeload: unwarranted p53 signaling induced by Cas9

ORCID Icon, ORCID Icon & ORCID Icon
Article: 1789419 | Received 22 Jun 2020, Accepted 25 Jun 2020, Published online: 14 Jul 2020

Figures & data

Figure 1. Implications of Cas9-induced p53 signaling. A summary of the biological, practical and clinical concerns associated with CRISPR associated protein 9 (Cas9)-induced tumor protein TP53 (p53) signaling. These concerns raise open questions that need to be tackled: from a basic science perspective, it will be important to understand the mechanisms that lead to nonspecific DNA cutting and to p53 signaling; from a routine lab work perspective, it will be helpful to determine best practices to monitor and alleviate Cas9-induced signaling; from a therapeutics perspective, it will be important to evaluate this issue in clinically-relevant settings. dCas9, catalytically-dead Cas9.

Figure 1. Implications of Cas9-induced p53 signaling. A summary of the biological, practical and clinical concerns associated with CRISPR associated protein 9 (Cas9)-induced tumor protein TP53 (p53) signaling. These concerns raise open questions that need to be tackled: from a basic science perspective, it will be important to understand the mechanisms that lead to nonspecific DNA cutting and to p53 signaling; from a routine lab work perspective, it will be helpful to determine best practices to monitor and alleviate Cas9-induced signaling; from a therapeutics perspective, it will be important to evaluate this issue in clinically-relevant settings. dCas9, catalytically-dead Cas9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.